Sökning: onr:"swepub:oai:DiVA.org:uu-460102" >
Allogeneic Transpla...
-
Metheny, LelandUniv Hosp Cleveland Med Ctr, Seidman Canc Ctr, 11100 Euclid Ave, Cleveland, OH 44122 USA.
(författare)
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults
- Artikel/kapitelEngelska2021
Förlag, utgivningsår, omfång ...
-
Elsevier,2021
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-460102
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-460102URI
-
https://doi.org/10.1016/j.jtct.2021.08.010DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:148204000URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Patients who develop therapy-related myeloid neoplasm, either myelodysplastic syndrome (t-MDS) or acute myelogenous leukemia (t-AML), have a poor prognosis. An earlier Center for International Blood and Marrow Transplant Research (CIBMTR) analysis of 868 allogeneic hematopoietic cell transplantations (allo-HCTs) performed between 1990 and 2004 showed a 5-year overall survival (OS) and disease-free survival (DFS) of 22% and 21%, respectively. Modern supportive care, graft-versus-host disease prophylaxis, and reduced-intensity conditioning (RIC) regimens have led to improved outcomes. Therefore, the CIBMTR analyzed 1531 allo-HCTs performed in adults with t-MDS (n = 759) or t-AML (n = 772) between and 2000 and 2014. The median age was 59 years (range, 18 to 74 years) for the patients with t-MDS and 52 years (range, 18 to 77 years) for those with tAML. Twenty-four percent of patients with t-MDS and 11% of those with t-AML had undergone a previous autologous (auto-) HCT. A myeloablative conditioning (MAC) regimen was used in 49% of patients with t-MDS and 61% of patients with t-AML. Nonrelapse mortality at 5 years was 34% (95% confidence interval [CI], 30% to 37%) for patients with t-MDS and 34% (95% CI, 30% to 37%) for those with t-AML. Relapse rates at 5 years in the 2 groups were 46% (95% CI, 43% to 50%) and 43% (95% CI, 40% to 47%). Five-year OS and DFS were 27% (95% CI, 23% to 31%) and 19% (95% CI, 16% to 23%), respectively, for patients with t-MDS and 25% (95% CI, 22% to 28%) and 23% (95% CI, 20% to 26%), respectively, for those with t-AML. In multivariate analysis, OS and DFS were significantly better in young patients with low-risk t-MDS and those with t-AML undergoing HCT with MAC while in first complete remission, but worse for those with previous auto-HCT, higher-risk cytogenetics or Revised International Prognostic Scoring System score, and a partially matched unrelated donor. Relapse remains the major cause of treatment failure, with little improvement seen over the past 2 decades. These data mandate caution when recommending allo-HCT in these conditions and indicate the need for more effective antineoplastic approaches before and after allo-HCT.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Callander, Natalie S.Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.,Dokkyo Med Univ, Dept Hematol & Oncol, Mibu, Tochigi, Japan.
(författare)
-
Hall, Aric C.Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA.
(författare)
-
Zhang, Mei-JeiMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA.
(författare)
-
Bo-Subait, KhalidMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.
(författare)
-
Wang, Hai-LinMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.
(författare)
-
Agrawal, VaibhavStanford Univ, Sch Med, Dept Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA.
(författare)
-
Samer Al-Homsi, A.New York Univ Langone Hlth, New York, NY USA.,Columbia Univ, Dept Med, Irving Med Ctr, Bone Marrow Transplant & Cell Therapy Program, New York, NY USA.
(författare)
-
Assal, AmerColumbia Univ, Dept Med, Irving Med Ctr, Bone Marrow Transplant & Cell Therapy Program, New York, NY USA.,Mayo Clin, Blood & Marrow Transplantat Program, Div Hematol Oncol, Jacksonville, FL 32224 USA.;Univ Calgary, Calgary, AB, Canada.,Univ Maryland, Greenebaum Comprehens Canc Ctr, Dept Med, Blood & Marrow Transplantat Program,Div Hematol O, Baltimore, MD 21201 USA.
(författare)
-
Bacher, UlrikeUniv Bern, Univ Hosp Bern, Inselspital, Dept Hematol, Bern, Switzerland.
(författare)
-
Beitinjaneh, AmerUniv Miami, Div Transplantat & Cellular Therapy, Miami, FL USA.
(författare)
-
Bejanyan, NelliH Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Minneapolis, MN USA.
(författare)
-
Bhatt, Vijaya RajUniv Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA.
(författare)
-
Bredeson, ChrisOttawa Hosp, Blood & Marrow Transplant Program, Ottawa, ON, Canada.;Ottawa Hosp Res Inst, Ottawa, ON, Canada.
(författare)
-
Byrne, MichaelVanderbilt Univ, Med Ctr, Nashville, TN USA.
(författare)
-
Cairo, MitchellNew York Med Coll, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA.
(författare)
-
Cerny, JanUniv Massachusetts, Med Ctr, Dept Med, Div Hematol Oncol, Worcester, MA USA.
(författare)
-
DeFilipp, ZachariahMassachusetts Gen Hosp, Hematopoiet Cell Transplant & Cellular Therapy Pr, Boston, MA 02114 USA.
(författare)
-
Diaz Perez, Miguel AngelHosp Infantil Univ Nino Jesus, Dept Hematol Oncol, Madrid, Spain.
(författare)
-
Freytes, César O.Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
(författare)
-
Ganguly, SiddharthaUniv Kansas Hlth Syst, Div Hematol Malignancy & Cellular Therapeut, Kansas City, KS USA.
(författare)
-
Grunwald, Michael R.Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA.
(författare)
-
Hashmi, ShahrukhMayo Clin, Dept Internal Med, Rochester, MN USA.;Sheikh Shakhbout Med City, Dept Med, Abu Dhavi, U Arab Emirates.
(författare)
-
Hildebrandt, Gerhard C.Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.
(författare)
-
Inamoto, YoshihiroNatl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan.
(författare)
-
Kanakry, Christopher G.NCI, Expt Transplantat & Immunotherapy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
(författare)
-
Kharfan-Dabaja, Mohamed A.Mayo Clin, Blood & Marrow Transplantat Program, Div Hematol Oncol, Jacksonville, FL 32224 USA.;Univ Calgary, Calgary, AB, Canada.
(författare)
-
Lazarus, Hillard M.Case Western Reserve Univ, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA.
(författare)
-
Lee, Jong WookCatholic Univ Korea, Seoul St Marys Hosp, Div Hematol, Seoul, South Korea.
(författare)
-
Nathan, SunitaRush Univ, Med Ctr, Sect Bone Marrow Transplant & Cell Therapy, Chicago, IL 60612 USA.
(författare)
-
Nishihori, TaigaH Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Minneapolis, MN USA.
(författare)
-
Olsson, Richard F.Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Dept Lab Med, Stockholm, Sweden(Swepub:uu)riols677
(författare)
-
Ringdén, OlovKarolinska Institutet,Karolinska Inst, Translat Cell Therapy Grp, CLINTEC Clin Sci Intervent & Technol, Stockholm, Sweden.
(författare)
-
Rizzieri, DavidDuke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA.
(författare)
-
Savani, Bipin N.Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA.
(författare)
-
Savoie, Mary Lynn
(författare)
-
Seo, SachikoDokkyo Med Univ, Dept Hematol & Oncol, Mibu, Tochigi, Japan.,NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.
(författare)
-
van der Poel, MarjoleinMaastricht Univ, Med Ctr, Maastricht, Netherlands.
(författare)
-
Verdonck, Leo F.Isala Clin, Dept Hematol Oncol, Zwolle, Netherlands.
(författare)
-
Wagner, John L.Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA.
(författare)
-
Yared, Jean A.Univ Maryland, Greenebaum Comprehens Canc Ctr, Dept Med, Blood & Marrow Transplantat Program,Div Hematol O, Baltimore, MD 21201 USA.
(författare)
-
Hourigan, Christopher S.NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.
(författare)
-
Kebriaei, PartowUniv Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA.
(författare)
-
Litzow, MarkMayo Clin Rochester, Div Hematol, Rochester, MN USA.;Mayo Clin Rochester, Transplant Ctr, Rochester, MN USA.
(författare)
-
Sandmaier, Brenda M.Univ Washington, Div Med Oncol, Seattle, WA 98195 USA.;Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.
(författare)
-
Saber, WaelMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.
(författare)
-
Weisdorf, DanielUniv Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.
(författare)
-
de Lima, MarcosUniv Hosp Case Med Ctr, Seidman Canc Ctr, Dept Med, Cleveland, OH USA.
(författare)
-
Freytes, EO
(författare)
-
Univ Hosp Cleveland Med Ctr, Seidman Canc Ctr, 11100 Euclid Ave, Cleveland, OH 44122 USA.Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Transplantation and Cellular Therapy: Elsevier27:11, s. 923.e1-923.e122666-63752666-6367
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Metheny, Leland
-
Callander, Natal ...
-
Hall, Aric C.
-
Zhang, Mei-Jei
-
Bo-Subait, Khali ...
-
Wang, Hai-Lin
-
visa fler...
-
Agrawal, Vaibhav
-
Samer Al-Homsi, ...
-
Assal, Amer
-
Bacher, Ulrike
-
Beitinjaneh, Ame ...
-
Bejanyan, Nelli
-
Bhatt, Vijaya Ra ...
-
Bredeson, Chris
-
Byrne, Michael
-
Cairo, Mitchell
-
Cerny, Jan
-
DeFilipp, Zachar ...
-
Diaz Perez, Migu ...
-
Freytes, César O ...
-
Ganguly, Siddhar ...
-
Grunwald, Michae ...
-
Hashmi, Shahrukh
-
Hildebrandt, Ger ...
-
Inamoto, Yoshihi ...
-
Kanakry, Christo ...
-
Kharfan-Dabaja, ...
-
Lazarus, Hillard ...
-
Lee, Jong Wook
-
Nathan, Sunita
-
Nishihori, Taiga
-
Olsson, Richard ...
-
Ringdén, Olov
-
Rizzieri, David
-
Savani, Bipin N.
-
Savoie, Mary Lyn ...
-
Seo, Sachiko
-
van der Poel, Ma ...
-
Verdonck, Leo F.
-
Wagner, John L.
-
Yared, Jean A.
-
Hourigan, Christ ...
-
Kebriaei, Partow
-
Litzow, Mark
-
Sandmaier, Brend ...
-
Saber, Wael
-
Weisdorf, Daniel
-
de Lima, Marcos
-
Freytes, EO
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
Transplantation ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet